Trial intelligence / Profile preview

Propranolol vs Discontinuation After Variceal Banding Ligation

NCT02740166Phase 4Unknown

Sponsor
Kaohsiung Veterans General Hospital
Start
Jun 2013
Primary completion
Jan 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of propranolol in esophageal varices, sponsored by Kaohsiung Veterans General Hospital. Primary endpoints: Recurrent esophageal variceal bleeding at 6 years and Mortality or liver transplantation at 6 years. Status: unknown.

02

Drugs

propranolol
03

Conditions

esophageal varices

Beyond the preview

Go deeper on NCT02740166.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02740166.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call